FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: ADVISORY COMMITTEE; PULMONARY-ALLERGY DRUGS ADVISORY COMMITTEE; RENEWAL

WASHINGTON, May 26 -- Food and Drug Administration has issued a notice called: Advisory Committee; Pulmonary-Allergy Drugs Advisory Committee; Renewal.

The notice was published in the Federal Register on May 26 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA) is announcing the renewal of the Pulmonary-Allergy Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Pulmonary-Allergy Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the May 30, 2028, expiration date.

For...